Patient’s HLA Genotype Is Associated With the Risk of Central Nervous System Dissemination and Clinical Disease Presentation in Diffuse Large B-cell Lymphoma

RIINA K. OLLIKAINEN; ANTTI SIPPOLA; TAINA TURPEENNIEMI-HUJANEN; HANNE KUITUNEN; KATJA PORVARI; KIRSI-MARIA HAAPASAARI; MILLA E.L. KUUSISTO; TUULA KLAAVUNIEMI; OUTI KUITTINEN

doi:10.21873/anticanres.17143

Article Information

vol. 44 no. 8 3255-3259

DOI

https://doi.org/10.21873/anticanres.17143

PMID

39060054

Published By

International Institute of Anticancer Research

Print ISSN

0250-7005

Online ISSN

1791-7530

History

Received May 29, 2024
Revision received June 21, 2024
Accepted June 24, 2024
Published online July 26, 2024.

Copyright © 2024 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).

Author Information

RIINA K. OLLIKAINEN¹,² ⇑,
ANTTI SIPPOLA³,
TAINA TURPEENNIEMI-HUJANEN²,³,
HANNE KUITUNEN²,³,
KATJA PORVARI³,
KIRSI-MARIA HAAPASAARI⁴,
MILLA E.L. KUUSISTO³,⁵,⁶,
TUULA KLAAVUNIEMI¹ and
OUTI KUITTINEN¹,³,⁷

¹Institute of Clinical Medicine, Faculty of Health Medicine, University of Eastern Finland, Kuopio, Finland;
²Cancer Center, Oulu University Hospital, Oulu, Finland;
³Translational Medicine Research Unit, University of Oulu, Oulu, Finland;
⁴Department of Pathology, Oulu University Hospital and University of Oulu, Oulu, Finland;
⁵Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland;
⁶Department of Internal Medicine, Länsi-Pohja Central Hospital, Kemi, Finland;
⁷Cancer Center, Kuopio University Hospital, Kuopio, Finland

Correspondence to: Riina Karoliina Ollikainen (ORCID ID: 0000-0003-1135-0316), Kajaanintie 50, 90220 Oulu, Finland. Tel: +358 408205405, e-mail: riinolli{at}uef.fi

View Full Text